AktiePharma

ALPINE IMMUNE SCIENCES

WKN
ISIN
Ticker
WKN
Ticker
ISIN

Nasdaq
64,970 USD
+0,010 USD+0,02 %
Geld
64,970 USD
(146.000 Stk.)
Brief
64,990 USD
(8.700 Stk.)
Tagesvolumen
4.288.333 Stk.
Tagesspanne
64,970  –  65,000 USD
52W-Spanne
8,330  –  65,000 USD

Unternehmens­daten

Stammdaten zu ALPINE IMMUNE SCIENCES

WKN
A2DU89
ISIN
US02083G1004
Home-Symbol
ALPN
Symbol
34LA
Branche
Pharma
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Unbekannt
Land

Marktdaten

Marktkapitalisierung
Anzahl Aktien
Streubesitz

Alle Aktien des Unternehmens

Anteilseigner

Decheng Capital LLCFrazier Life Sciences Management LPAvoro Capital Advisor LLCBlackRock Fund AdvisorsT. Rowe Price Associates, Inc. (Investment Management)SSgA Funds Management, Inc.Cormorant Asset Management LPOrbiMed Advisors Private EquityAlpine Bioventures, GP, LLCThe Vanguard Group, Inc.Lynx1 Capital Management LPParadigm BioCapital Advisors LPDarwin Global Management Ltd.Commodore Capital LPOctagon Capital Advisors LPAvidity Partners Management LPGreat Point Partners LLCFranklin Advisers, Inc.Geode Capital Management LLCMorgan Stanley & Co. LLC
  • Decheng Capital LLC (12,77 %)
  • Frazier Life Sciences Management LP (9,20 %)
  • Avoro Capital Advisor LLC (8,81 %)
  • BlackRock Fund Advisors (4,77 %)
  • T. Rowe Price Associates, Inc. (Investment Management) (4,62 %)
  • SSgA Funds Management, Inc. (4,34 %)
  • Cormorant Asset Management LP (4,12 %)
  • OrbiMed Advisors Private Equity (4,09 %)
  • Alpine Bioventures, GP, LLC (4,01 %)
  • The Vanguard Group, Inc. (4,00 %)

Kontakt